What improvements would you like in Yahoo! Finance Message Boards? Please send us feedback.
Re: Inferon Lambda      4-Nov-09 11:38 am    
The next INFORM trial is almost completely irrelevent inre IFN since it treats all patients after 28 days with SOC. The interesting trial will be the subsequent phase of trials, which are slated to start in second half 2010 and will be a comparison of ETR and SVR for all oral cocktails vs combos with SOC.

I'd fully expect the RVR comparison to make SOC look pathetic. But the real interesting data is going to be the ETR/SVR data - where I expect phenominal ETR rate (95+ pct) and an equally phenominal relapse rate (say 30+ pct in 24 weeks and 45+ pct over, say, 2 years). But note that this guess of mine is just that - a guess, based upon the fact that to date we have not yet cured ANY chronic viral infection without specifically and intentionally manipulating the immune system. Even AIDS, which has boatloads more money thrown at it, has only seen hints of preventing relapse after anti-viral cocktail - and then only by manipulating the immune system.
Rating :
 (1 Rating)
Rate it:
awful/not related to \pooraveragegoodexcellent

clarksterh

Male


View Messages

Ignore User

Report Abuse

< Previous Message |   Next Message >
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Messages in Topic

Minimum rating: What's this?
  Subject Author Rating Time of Post (ET)  
 
Copy and paste from CP Too late for lambda. The INF...
jkro65 Rate it 3-Nov-09 09:07 pm  
 
someone better tell BMS, they have invested $200MM...
bioimmunoma... Rate it 4-Nov-09 09:58 am  
 
Re: Inferon Lambda
clarksterh (1 Rating) 4-Nov-09 11:38 am  
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

ZymoGenetics, Inc. (ZGEN)

Chart for ZymoGenetics, Inc. (ZGEN)
At 4:00PM ET: 6.35 Down 0.02 (0.31%)
Symbol Lookup